Form 4 for AGEN AGENUS INC
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-02 · accession 0000899243-22-004867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-04 | 2022-02-02 | AGEN | ARMEN GARO H | COB, CEO, Dir | A - Grant | $2.51 | +237.0K | 1.01M | +31% | +$594.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-02 | A | A | 237,011 | $2.51 | 1,007,784 | D | — | — | (F1) Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary. (F2) $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date. |